ロード中...
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer
Non-small-cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases and is the leading cause of cancer-related deaths. Most NSCLC patients are diagnosed with advanced disease and require systemic treatment. Despite emerging advances in chemotherapy and immunotherapy, the prognosis of...
保存先:
| 出版年: | Drugs |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8154809/ https://ncbi.nlm.nih.gov/pubmed/33226527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01445-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|